The physiological bone remodelling, through the release of different molecules, provides a fertile soil for the growth of tumor cells, such as TGF-β, IGF I and II, platelet-derived growth factor (PDGF), fibroblast growth factor (FGF), and bone morphogenetic proteins (BMPs) [33,34]. The gene discussed is TGFB1; the disease is neoplasm.